SAN DIEGO--(BUSINESS WIRE)--As of May 2019, California Protons Cancer Therapy Center is now affiliated with UC San Diego Health Cancer Network, giving more patients access to world-class, lifesaving proton therapy treatment provided by radiation oncologists from Moores Cancer Center at UC San Diego Health, San Diego’s only National Cancer Institute-Designated Comprehensive Cancer Center.

“California Protons is designed to be a regional resource for treating physicians and patients seeking cancer treatment options,” said Andrew Chang, MD, President of Proton Doctors Professional Corporation physician group at California Protons. “We are excited to be affiliated with UC San Diego Health Cancer Network, in addition to Rady Children’s Hospital, enabling us to utilize our services and premier technology to help even more people with cancer.”

The Center, located at 9730 Summers Ridge Road in San Diego, has been in operation for five years, with California Protons operating it since December 2017. California Protons’ oncology team consists of some of the most experienced radiation oncologists in the proton space, internationally recognized and sought out by patients from around the world. With over 50 years of combined experience in proton therapy, these physicians have treated more than 15,000 patients with proton therapy.
“UC San Diego Health’s multidisciplinary team approach allows us to provide our patients with leading-edge cancer therapies without needing to leave San Diego,” said Arno Mundt, MD, Chair of the Department of Radiation Medicine and Applied Sciences at University of California San Diego School of Medicine. “Having proton therapy as another tool available to our physicians is a valuable benefit for our patients who will have seamless coordination of care.”

California Protons and UC San Diego Health will work together on research to further support protocols for breast cancer, prostate cancer, head and neck cancers, and more. UC San Diego’s extensive research experience will further enhance much needed proton therapy research. As an academic health system, UC San Diego Health is conducting more than 300 clinical trials that are often unavailable anywhere else.

“The results of clinical trials and research studies are critical pieces of information physicians use when deciding how to best treat our patients,” said James Urbanic, MD, UC San Diego Health radiation oncologist and Chief Program Manager for California Protons. “This affiliation will provide both parties access to the patient data and research structures needed to participate in, and help lead innovative and much needed research.”

Rad Oncology Homepage